BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22341488)

  • 21. Clinical Association of a Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) in Patients with Systemic Lupus Erythematosus.
    Bassyouni IH; Fawzi S; Gheita TA; Bassyouni RH; Nasr AS; El Bakry SA; Afifi N
    Immunol Invest; 2017 Jan; 46(1):38-47. PubMed ID: 27648678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profile of soluble cytokine receptors in Crohn's disease.
    Gustot T; Lemmers A; Louis E; Nicaise C; Quertinmont E; Belaiche J; Roland S; Van Gossum A; Devière J; Franchimont D
    Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serum level of TNF-alpha receptor type II better correlates with severity of Crohn's disease than other cytokines and conventional clinical activity indicators].
    Kohut M; Kacperek-Hartleb T; Sojka D; Hartleb M
    Pol Merkur Lekarski; 2010 Jun; 28(168):454-8. PubMed ID: 20642103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease.
    Schinzari F; Armuzzi A; De Pascalis B; Mores N; Tesauro M; Melina D; Cardillo C
    Clin Pharmacol Ther; 2008 Jan; 83(1):70-6. PubMed ID: 17507924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
    Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M
    Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune activation and nutritional status in adult Crohn's disease patients.
    Reimund JM; Arondel Y; Escalin G; Finck G; Baumann R; Duclos B
    Dig Liver Dis; 2005 Jun; 37(6):424-31. PubMed ID: 15893281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of C-reactive protein for predicting activity level of Crohn's disease.
    Chamouard P; Richert Z; Meyer N; Rahmi G; Baumann R
    Clin Gastroenterol Hepatol; 2006 Jul; 4(7):882-7. PubMed ID: 16630759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission.
    Valentini L; Schaper L; Buning C; Hengstermann S; Koernicke T; Tillinger W; Guglielmi FW; Norman K; Buhner S; Ockenga J; Pirlich M; Lochs H
    Nutrition; 2008; 24(7-8):694-702. PubMed ID: 18499398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for the participation of soluble triggering receptor expressed on myeloid cells-1 in the systemic inflammatory response syndrome after multiple trauma.
    Giamarellos-Bourboulis EJ; Mouktaroudi M; Tsaganos T; Koutoukas P; Spyridaki E; Pelekanou A; Kotzampassi K
    J Trauma; 2008 Dec; 65(6):1385-90. PubMed ID: 19077631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease.
    Maser EA; Villela R; Silverberg MS; Greenberg GR
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1248-54. PubMed ID: 16931170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble triggering receptor expressed on myeloid cells 1 and the diagnosis of sepsis.
    Barati M; Bashar FR; Shahrami R; Zadeh MH; Taher MT; Nojomi M
    J Crit Care; 2010 Jun; 25(2):362.e1-6. PubMed ID: 19914031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease.
    Schmidt C; Wittig BM; Moser C; Zeitz M; Stallmach A
    Aliment Pharmacol Ther; 2006 Jul; 24(2):343-50. PubMed ID: 16842461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Improvement of bone metabolism after infliximab therapy in Crohn's disease].
    Miheller P; Muzes G; Zágoni T; Tóth M; Rácz K; Tulassay Z
    Orv Hetil; 2005 Jul; 146(28):1477-80. PubMed ID: 16130441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucosal healing with methotrexate in Crohn's disease: a prospective comparative study with azathioprine and infliximab.
    Laharie D; Reffet A; Belleannée G; Chabrun E; Subtil C; Razaire S; Capdepont M; de Lédinghen V
    Aliment Pharmacol Ther; 2011 Mar; 33(6):714-21. PubMed ID: 21235604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble form of triggering receptor expressed on myeloid cells-1 (sTREM-1) as a diagnostic marker of serious bacterial infection in febrile infants less than three months of age.
    Chen HL; Hung CH; Tseng HI; Yang RC
    Jpn J Infect Dis; 2008 Jan; 61(1):31-5. PubMed ID: 18219131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C; Backmerhoff F; Schumacher B; Niederau C
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) detection in cancer patients: a prognostic marker for lung metastases from solid malignancies.
    Karapanagiotou EM; Pelekanou E; Charpidou A; Tsaganos T; Anagnostou V; Plachouras D; Giamarellos-Bourboulis EJ; Syrigos KN
    Anticancer Res; 2008; 28(2B):1411-5. PubMed ID: 18505088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.